BioDrugs : Impact Factor & More

eISSN: 1179-190XpISSN: 1173-8804

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Aims and Scope of BioDrugs

BioDrugs is a peer-reviewed pharmacology journal. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. It has a 2020 impact factor of 5.807. It is published by Adis International (SpringerNature). Less

BioDrugs Key Metrics

CiteScore
10.5
Eigenfactor
0.001 - 0.005
H-Index
76
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.74

Topics Covered on BioDrugs

BioDrugs Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ADIS INT LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in BioDrugs ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BioDrugs

Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer.
  • 1 May 2025
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature Review.
  • 1 May 2025
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Understanding IgM Structure and Biology to Engineer New Antibody Therapeutics.
  • 1 May 2025
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Real-World Evidence on the Effectiveness and Safety of Spesolimab in the Treatment of Generalized Pustular Psoriasis Flares: A Case Series.
  • 1 May 2025
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer.
  • 1 May 2025
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature Review.
  • 1 May 2025
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Understanding IgM Structure and Biology to Engineer New Antibody Therapeutics.
  • 1 May 2025
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Real-World Evidence on the Effectiveness and Safety of Spesolimab in the Treatment of Generalized Pustular Psoriasis Flares: A Case Series.
  • 1 May 2025
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Compare Similar Journals with BioDrugs

Select Journals to Compare with BioDrugs
Total journals - 10
You can select up to 3 Journals at a time

Annals of the Rheumatic Diseases

Publisher: BMJ PUBLISHING GROUP

Journal of Clinical Oncology

Publisher: LIPPINCOTT WILLIAMS & WILKINS

Annals of Oncology

Publisher: ELSEVIER

Expert Opinion on Biological Therapy

Publisher: TAYLOR & FRANCIS LTD

Frontiers in Pharmacology

Publisher: FRONTIERS MEDIA SA

PLoS ONE

Publisher: PUBLIC LIBRARY SCIENCE

Medicine

Publisher: Elsevier

Rheumatology

Publisher: OXFORD UNIV PRESS

Scientific Reports

Publisher: NATURE PORTFOLIO

Cancer Research

Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
BioDrugs
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

Get detailed Journal comparison report on your email by signing up

Check if your research matches the topics covered in BioDrugs?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on BioDrugs